Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Reduced by Mitsubishi UFJ Asset Management UK Ltd.

Mitsubishi UFJ Asset Management UK Ltd. lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 69.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,600 shares of the medical equipment provider’s stock after selling 3,700 shares during the quarter. Mitsubishi UFJ Asset Management UK Ltd.’s holdings in Intuitive Surgical were worth $786,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the business. Raymond James & Associates raised its stake in Intuitive Surgical by 25.4% during the 3rd quarter. Raymond James & Associates now owns 380,886 shares of the medical equipment provider’s stock valued at $187,118,000 after acquiring an additional 77,119 shares in the last quarter. Slow Capital Inc. increased its holdings in shares of Intuitive Surgical by 0.7% during the third quarter. Slow Capital Inc. now owns 40,632 shares of the medical equipment provider’s stock valued at $19,961,000 after purchasing an additional 267 shares during the period. Friedenthal Financial bought a new stake in shares of Intuitive Surgical during the third quarter valued at about $51,000. Capital Investment Advisors LLC lifted its holdings in Intuitive Surgical by 7.3% in the third quarter. Capital Investment Advisors LLC now owns 778 shares of the medical equipment provider’s stock worth $382,000 after purchasing an additional 53 shares during the period. Finally, Moss Adams Wealth Advisors LLC grew its position in Intuitive Surgical by 20.1% in the 3rd quarter. Moss Adams Wealth Advisors LLC now owns 627 shares of the medical equipment provider’s stock valued at $308,000 after buying an additional 105 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of research analyst reports. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research note on Friday. Truist Financial increased their price target on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Morgan Stanley boosted their price objective on Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a research note on Monday, July 15th. BTIG Research set a $535.00 target price on Intuitive Surgical in a research note on Friday. Finally, Robert W. Baird boosted their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday. One analyst has rated the stock with a sell rating, six have given a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $503.75.

Intuitive Surgical Trading Up 10.0 %

NASDAQ:ISRG traded up $47.42 during trading hours on Friday, hitting $521.15. 4,059,157 shares of the stock traded hands, compared to its average volume of 1,478,565. The firm has a 50 day moving average price of $483.85 and a 200 day moving average price of $437.79. The firm has a market cap of $184.85 billion, a price-to-earnings ratio of 94.07, a PEG ratio of 5.40 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $523.34.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The firm had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. During the same period in the prior year, the business earned $1.18 EPS. The business’s revenue for the quarter was up 14.5% on a year-over-year basis. Research analysts predict that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Insider Activity

In related news, EVP Robert Desantis sold 1,413 shares of the firm’s stock in a transaction that occurred on Friday, July 26th. The shares were sold at an average price of $438.60, for a total transaction of $619,741.80. Following the completion of the sale, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,414,931.60. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares in the company, valued at approximately $1,461,006.84. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Robert Desantis sold 1,413 shares of Intuitive Surgical stock in a transaction on Friday, July 26th. The shares were sold at an average price of $438.60, for a total value of $619,741.80. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,414,931.60. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 53,120 shares of company stock worth $25,528,753 in the last 90 days. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.